J. Safra Sarasin Holding’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.57M Sell
111,341
-28,897
-21% -$949K 0.05% 186
2026
Q1
$5.22M Buy
140,238
+4,751
+4% +$196K 0.09% 136
2025
Q4
$6.34M Sell
135,487
-22,012
-14% -$952K 0.1% 128
2025
Q3
$6.6M Sell
157,499
-6,539
-4% -$287K 0.11% 125
2025
Q2
$7.22M Sell
164,038
-5,955
-4% -$270K 0.12% 124
2025
Q1
$8.56M Buy
+169,993
New +$8.43M 0.16% 110

Other funds holding G

J. Safra Sarasin Holding's G Position: Q2 2026 in Review

J. Safra Sarasin Holding reduced its Genpact (G) stake by 21% in Q2 2026, selling an estimated $949K and leaving 111,341 shares worth $3.57M. The position accounts for 0.05% of the portfolio, ranked #186.

J. Safra Sarasin Holding first reported a position in G in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.56M in Q1 2025. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • J. Safra Sarasin Holding held 111,341 shares of Genpact worth $3.57M as of Q2 2026.
  • J. Safra Sarasin Holding sold 28,897 Genpact shares in Q2 2026, an estimated $949K.
  • Genpact made up 0.05% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #186 holding.
  • J. Safra Sarasin Holding first reported a position in Genpact in Q1 2025 and has held it in 6 quarters since.
  • J. Safra Sarasin Holding's Genpact position peaked at $8.56M in Q1 2025.
  • 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.